Search CatalystAlert
Search for companies, drugs, and catalysts
Search CatalystAlert
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
1
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
4 competitors in Chronic Kidney Disease
View Full LandscapeNo patent data available. Pre-approval drugs may not have Orange Book listings.
Kerendia
Kerendia is indicated for the treatment of chronic kidney disease (with albuminuria) associated with type 2 diabetes in adults. For study results with respect to renal and cardiovascular events, see section 5.1.
View on EMAColorectal Neoplasms
Pneumonia, Bacterial
Overactive Bladder
Acute Coronary Syndrome
Oral Contraceptive